INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

A study led by Turkish researcher Pinar Ayata unveiled a critical mechanism involving microglia—specialized immune cells in ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

SCIENTISTS investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...

Alzheimer's is the most common cause of dementia and researchers say their findings could lead to treatments that could slow ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...